Abstract
Sleep disturbances are very common in cancer patients. They are part of a symptom cluster with fatigue and pain that greatly affect quality of life in these patients. Lung cancer patients are found to have the highest prevalence of sleep disturbances. However, these disturbances have not been as well-studied in the lung cancer patients. Though insomnia is the most common disorder seen in these patients, other sleep disorders like excessive daytime sleepiness, limb movement disorders and circadian rhythm disorders have also been described. Treatment of these disorders may affect the prognosis of patients with lung cancer. More studies should be done to elucidate the details of sleep disturbances in lung cancer patients.
Keywords: Lung cancer and sleep disturbances, insomnia and lung cancer, restless legs syndrome and cancer
Current Respiratory Medicine Reviews
Title: Sleep Disturbances in Lung Cancer Patients
Volume: 5 Issue: 4
Author(s): Kanta Velamuri
Affiliation:
Keywords: Lung cancer and sleep disturbances, insomnia and lung cancer, restless legs syndrome and cancer
Abstract: Sleep disturbances are very common in cancer patients. They are part of a symptom cluster with fatigue and pain that greatly affect quality of life in these patients. Lung cancer patients are found to have the highest prevalence of sleep disturbances. However, these disturbances have not been as well-studied in the lung cancer patients. Though insomnia is the most common disorder seen in these patients, other sleep disorders like excessive daytime sleepiness, limb movement disorders and circadian rhythm disorders have also been described. Treatment of these disorders may affect the prognosis of patients with lung cancer. More studies should be done to elucidate the details of sleep disturbances in lung cancer patients.
Export Options
About this article
Cite this article as:
Velamuri Kanta, Sleep Disturbances in Lung Cancer Patients, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112500
DOI https://dx.doi.org/10.2174/157339809790112500 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protocatechuic Acid and Human Disease Prevention: Biological Activities and Molecular Mechanisms
Current Medicinal Chemistry CREB, Synapses and Memory Disorders: Past Progress and Future Challenges
Current Drug Targets - CNS & Neurological Disorders Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation
Current Pharmaceutical Design Vanilloid Receptor Antagonists: Emerging Class of Novel Anti-Inflammatory Agents for Pain Management
Current Pharmaceutical Design Physiological Roles of Neuronal Nicotinic Receptors Subtypes: New Insights on the Nicotinic Modulation of Neurotransmitter Release, Synaptic Transmission and Plasticity
Current Topics in Medicinal Chemistry New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Coarse Classification to Region-Scalable Refining for White Matter Lesions Segmentation in Multi-Channel MRI
CNS & Neurological Disorders - Drug Targets Origin and Evolution of China Pharmacopoeia and Its Implication for Traditional Medicines
Mini-Reviews in Medicinal Chemistry Anti-proliferative Properties of miR-20b and miR-363 from the miR-106a-363 Cluster on Human Carcinoma Cells
MicroRNA Conformation as the Therapeutic Target for Neurodegenerative Diseases
Current Alzheimer Research Subcellular Trafficking in Rhabdovirus Infection and Immune Evasion: A Novel Target for Therapeutics
Infectious Disorders - Drug Targets Antidepressant Activity of 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin- 6-amine hydrochloride (TC-2153): Comparison with Classical Antidepressants
Letters in Drug Design & Discovery Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved
Current Neuropharmacology Panic and the Brainstem: Clues from Neuroimaging Studies
CNS & Neurological Disorders - Drug Targets Recent Understanding of Leukocytapheresis (LCAP) for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design Genetically-Modified Human Pluripotent Stem Cells: New Hopes for the Understanding and the Treatment of Neurological Diseases?
Current Gene Therapy Managed Health Care and Child Mental Health Services: Where Is Horton to Hear the Whos?
Current Pediatric Reviews Toward a Developmentally Centered Approach to Adolescent Alcohol and Substance Use Treatment
Current Drug Abuse Reviews Anti-Inflammatory Agents from Plants: Progress and Potential
Current Medicinal Chemistry